In patients with cystic fibrosis, CMTX-101, an immune-enabling antibody therapy, lowered four inflammatory biomarkers and ...

ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced the launch of ResQ215B, a Phase 2 ...

Biomarker analyses provided proof of a mechanism during combination therapy.Yap and his colleagues observed increased CD8+ T cell infiltration and activation in tumors, reduced the regulatory T ...

For years, scientists have hoped to harness the immune system to attack cancer using a group of drugs known as CD40 agonist antibodies. On paper, they looked like a breakthrough. In mice and other lab ...

Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...

The lower hinge of immunoglobulin G (IgG), an overlooked part of the antibody, acts as a structural and functional control hub, according to a study by researchers at Science Tokyo. Deleting a single ...

The single-dose injection can help prevent RSV. Learn how it works and when your baby may be eligible.

Antibody-based immune therapy could become a key weapon in the fight against bird flu after trials in monkeys successfully prevented severe illness and death from the infection. The preventative ...

Scientists at the Icahn School of Medicine at Mount Sinai have identified an important immune response that helps explain why ...

Shaji Kumar, MD, Mayo Clinic, highlights linvoseltamab’s dosing regimen, adverse effect profile, and management strategies. He speaks in particular about cytokine release syndrome, which although ...

The pause affects Sotrovimab from GlaxoSmithKline. The federal government is sharply pulling back on one of the monoclonal antibody treatments authorized for COVID-19, pausing its use across eight ...